Latest News
NaviFUS® Model 101 has been chosen for the 2022 Edison Awards Outpatient Treatment Finalist
2022-02-15

Source: NaviFUS

NaviFus is proud to announce NaviFUS® Model 101 has been chosen for the 2022 Edison Awards Finalists in Outpatient Treatment.

The Finalists of the 2022 Edison Best New Product Awards® were chosen as the “best of the best” by 3000 of the world’s top senior business executives, academics, and innovation professionals.

"NaviFUS® is a focused ultrasound technology platform that provides personalized and transformative solutions for brain diseases like glioblastoma and epilepsy. It can non-invasively open the blood-brain-barrier to allow large-molecular weight drug delivery to previously unreachable parts of the brain and suppress seizures in epilepsy patients."

See the finalists of 2022 Edison Awards

More details on the NaviFUS system

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.
©Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
Address:16F.-1, No.3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.) Contact Number:(02)2655-8168 Fax:(02)2655-7978